Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 December 2023 | Story Anthony Mthembu | Photo Siyabonga Mazibuko and Anthony Mthembu
Sharon Pinky Kekana
Sharon Pinky Kekana: Deputy Minister in the Presidency for Planning, Monitoring and Evaluation.

The Gender Equality and Anti-Discrimination Office (GEADO) at the University of the Free State (UFS), in collaboration with the Central University of Technology (CUT), recently concluded its fourth bi-annual Gender Practitioners Community of Practice (CoP) conference in Clarens. The event, held from 28 to 30 November 2023, drew participation from gender practitioners representing all 26 Universities across the country. Distinguished guest speaker, Sharon Pinky Kekana, Deputy Minister in the Presidency for Planning, Monitoring and Evaluation, added valuable insights to the discussions.

Tumelo Rasebopye, Chairperson of the Gender Practitioners Community of Practice (CoP), outlined the conference’s key objectives, emphasising the need for thorough and robust engagement on issues raised in previous gatherings and the provision of essential tools for practitioners to implement upon their return to their institutions. Rasebopye stressed, ‘Part of the conference is to ensure that we engage in developing a common understanding and act at a baseline level to address the dynamics in our institutions.’’

The themes explored throughout the Conference

The conference delved into various themes through panel discussions and guest speaker sessions, covering topics such as masculinity, culture, and consent. However, the primary focus was on Gender-Based Violence and Femicide (GBVF), particularly pertinent during the 16 Days of Activism for No Violence against Women and Children.’ Kekana, in her address, considered the conference theme, ‘Accelerating actions to end gender-based violence & femicide: leaving no one behind,’ as a call to action. She urged attendees to continue to raise awareness about the devastating impact of GBVF on women, children and the nation as a whole, citing alarming statistics of 969 women murdered in the first three months of the year. 

Advocate Brenda Madumise, Co-Founder of the Wise Collective, highlighted flaws in the national justice system, pointing to prolonged sexual assault cases and the trauma inflicted on survivors during the waiting period.

Resolutions

Reflecting on the conference, Kekana deemed the discussions as an eye-opener, stressing an integrated approach involving various societal entities, including the church and religious leaders. The gender practitioners pledged to collaborate with groups such as the Student Representative Council (SRC) within their institutions to foster inclusivity.  Rasebopye affirmed, ‘’Our existence is fundamental towards the transformation of higher education, and these conferences will inform the necessary actions towards that course.’’

The GEADO, in partnership with CUT, continues to champion gender equality through informed and actionable discussions. The conference not only raised awareness about GBVF but also galvanized gender practitioners to play an active role in fostering inclusive environments within higher education institutions.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept